IMCR
Immunocore Holdings plc
Latest Form 4:Sale$23KbyGOLL JOHN (SVP, FINANCE & CAO) · filed Feb 19, 2026
Immunocore Holdings plc (IMCR) has 5 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Feb 19, 2026.
The most active filer is HEAD OF R&D Berman David M with 3 filings. Insiders have net sold $1.9M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Bahija Jallal
- Employees:524
- HQ:Abingdon, OX, GB
- IPO:2021-02-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
GOLL JOHNFirst filing | SVP, FINANCE & CAO | Sale | 698 | $23K | Feb 19 | SEC ↗ |
Jallal BahijaFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 11,474 | $371K | Feb 19 | SEC ↗ |
St Leger Tina AmberFirst filing | CHIEF HR OFFICER | Sale | 1,000 | $32K | Feb 19 | SEC ↗ |
| HEAD OF R&D | Sale | 5,965 | $193K | Feb 19 | SEC ↗ | |
Berman David MFirst filing | HEAD OF R&D | Sale | 31,341 | $1.3M | Dec 8 | SEC ↗ |
Berman David MFirst filing | HEAD OF R&D | Sale | 572 | $23K | Dec 8 | SEC ↗ |
Related companies
Immunocore Holdings plc is in the Healthcare sector.